Holista Colltech Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Holista Colltech Limited with three other
companies in this sector in AUSTRALIA :
Medlab Clinical Ltd
(2020
sales of 5.37 million Australian Dollars [US$3.89 million]
of which 67%
was Pharmaceutical Research),
Starpharma Holdings Limited
(7.12 million Australian Dollars [US$5.16 million]
of which 100%
was Discovery, development & commercial of D), and
Cellmid Limited
(7.48 million Australian Dollars [US$5.42 million]
of which 79%
was Advangen Japan).
Sales Analysis.
During the second
quarter of 2021, sales at Holista Colltech Limited totalled
A$3.58 million.
This is
an increase of 29.5%
from the A$2.77 million in sales at the company during the second quarter of 2020.
Holista Colltech Limited reported sales of A$7.13 million (US$5.17 million)
for the
year ending
December of 2020.
This
represents
a
decrease of 1.9%
versus 2019, when the company's sales were A$7.27 million.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Holista Colltech Limited had sales
of A$6.79 million.